You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Head and Neck Squamous Cell Carcinoma

Showing 9951 - 9975 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Systemic Scleroderma Trial in Duarte (procedure, drug, radiation)

Recruiting
  • Systemic Scleroderma
  • Allogeneic Hematopoietic Stem Cell Transplantation
  • +3 more
  • Duarte, California
    City of Hope Medical Center
Mar 7, 2022

Langerhans Cell Histiocytosis Trial in Canada, United States (Clofarabine)

Active, not recruiting
Has Results
  • Langerhans Cell Histiocytosis
  • Phoenix, Arizona
  • +14 more
Mar 28, 2022

B-ALL Trial in Hangzhou (ThisCART19A)

Recruiting
  • B-ALL
  • ThisCART19A
  • Hangzhou, Zhejiang, China
  • +1 more
Apr 26, 2022

Small Cell Lung Cancer Trial in Spain (BMS-986012, Cisplatin, Etoposide)

Active, not recruiting
  • Small Cell Lung Cancer
  • Barcelona, Spain
  • +3 more
Apr 25, 2022

Type 1 Diabetes Trial in Worldwide (CFZ533, Placebo)

Recruiting
  • Type 1 Diabetes Mellitus
  • Edegem, Antwerpen, Belgium
  • +16 more
Aug 23, 2022

NSCLC Trial in Worldwide (Afatinib)

Completed
Has Results
  • NSCLC
  • Köln, Germany
  • +4 more
Aug 23, 2022

Pulmonary Osteosarcoma Trial (RNA-LP vaccine)

Not yet recruiting
  • Pulmonary Osteosarcoma
  • RNA-LP vaccine
  • (no location specified)
Jan 25, 2023

NSCLC Stage IIIA, Radiotherapy Trial in Shanghai (PORT, Platinum-based two drug chemo (cisplatin/carboplatin + vinorelbine or

Unknown status
  • Non-small Cell Lung Cancer Stage IIIA
  • Radiotherapy
  • PORT
  • Platinum-based two drug chemotherapy (cisplatin/carboplatin + vinorelbine or cisplatin/carboplatin + pemetrexed regimen)
  • Shanghai, Shanghai, China
    Shanghai Chest Hospital
Nov 12, 2020

High Grade B-Cell Non-Hodgkin's Lymphoma, Intermediate Grade B-Cell Non-Hodgkin's Lymphoma, Recurrent B-Cell Non-Hodgkin

Not yet recruiting
  • High Grade B-Cell Non-Hodgkin's Lymphoma
  • +3 more
  • Anti-CD19-CAR CMV-specific T-lymphocytes
  • +9 more
  • Duarte, California
    City of Hope Medical Center
Apr 5, 2023

Frailty, Childhood Cancer Trial in Memphis (Dasatinib plus Quercetin, Fisetin)

Recruiting
  • Frailty
  • Childhood Cancer
  • Memphis, Tennessee
    St. Jude Children's Research Hospital
Jun 8, 2022

AML Trial in Hangzhou (NKG2D CAR-NK)

Recruiting
  • AML
  • NKG2D CAR-NK
  • Hangzhou, Zhejiang, China
  • +1 more
Feb 17, 2023

Advanced Hepatocellular Carcinoma Trial (Adebrelimab, Bevacizumab, SHR-8068)

Not yet recruiting
  • Advanced Hepatocellular Carcinoma
  • (no location specified)
Jun 30, 2022

Advanced Primary Liver Cancer Trial (IBR900 combined with Lenvatinib, IBR900 combined with Bevacizumab)

Not yet recruiting
  • Advanced Primary Liver Cancer
  • IBR900 combined with Lenvatinib
  • IBR900 combined with Bevacizumab
  • (no location specified)
Jun 6, 2022

Chronic Lymphocytic Leukemia, Mantle Cell Lymphoma Trial in United States (Ublituximab, Ibrutinib)

Completed
  • Chronic Lymphocytic Leukemia
  • Mantle Cell Lymphoma
  • Huntsville, Alabama
  • +17 more
Oct 21, 2022

DLBCL, Chronic Lymphocytic Leukemia, Follicular Lymphoma Trial in New Haven, Worcester, Dallas (ABBV-319)

Not yet recruiting
  • Diffuse Large B-Cell Lymphoma
  • +2 more
  • New Haven, Connecticut
  • +2 more
Aug 22, 2022

Lymphoma, Non-Hodgkin Lymphoma, DLBCL Trial run by the National Cancer Institute (NCI) (Venetoclax, Ibrutinib, Prednisone)

Recruiting
  • Lymphoma
  • +3 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Aug 20, 2022

Visualizing Beta Cells After Bariatric Surgery

Recruiting
  • Type 2 Diabetes Mellitus
  • 68Ga-exendin PET/CT
  • Arnhem, Gelderland, Netherlands
  • +1 more
Jun 16, 2022

Blood Vessel Study

Completed
  • Cardiovascular Disease
    • Research Triangle Park, North Carolina
      NIEHS Clinical Research Unit (CRU)
    Jan 25, 2023

    Refractory Metastatic Colorectal Cancer Trial in Hangzhou (NKG2D CAR-NK)

    Recruiting
    • Refractory Metastatic Colorectal Cancer
    • NKG2D CAR-NK
    • Hangzhou, Zhejiang, China
      The First Affiliated Hospital, Zhejiang University
    Jan 16, 2022

    Relapsing Multiple Sclerosis, Relapsing Remitting Multiple Sclerosis, Secondary Progressive Multiple Sclerosis Trial in United

    Recruiting
    • Relapsing Multiple Sclerosis
    • +2 more
    • Autologous Hematopoietic Stem Cell Transplantation
    • Best Available Therapy (BAT)
    • Palo Alto, California
    • +20 more
    Jan 25, 2023

    Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage IA Breast Cancer AJCC v8, Anatomic Stage IB Breast Cancer AJCC v8 Trial

    Suspended
    • Anatomic Stage I Breast Cancer AJCC v8
    • +23 more
    • Short-Term Fasting
    • Chemotherapy
    • Philadelphia, Pennsylvania
      Sidney Kimmel Cancer Center at Thomas Jefferson University
    Jan 23, 2023

    Lung Non-Small Cell Carcinoma, Recurrent Lung Non-Small Cell Carcinoma, Stage I Lung Cancer AJCC v8 Trial (Nivolumab,

    Withdrawn
    • Lung Non-Small Cell Carcinoma
    • +12 more
    • (no location specified)
    May 24, 2022

    Pancreatic Cancer Trial in Worldwide (5-FU, Oxaliplatine, Irinotecan)

    Active, not recruiting
    • Pancreatic Cancer
    • Odense, Denmark
    • +12 more
    Jun 25, 2021

    Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Acute Leukemia in Remission, Acute Lymphoblastic Leukemia

    Active, not recruiting
    • Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
    • +36 more
    • Buffalo, New York
      Roswell Park Cancer Institute
    Jan 23, 2023

    Lymphoma, B-Cell, Neurotoxicity Trial in Montpellier (Magnetic Resonance Imaging with contrast injection, Blood withdrawal,

    Not yet recruiting
    • Lymphoma, B-Cell
    • Neurotoxicity
    • Magnetic Resonance Imaging with contrast injection
    • +2 more
    • Montpellier, Occitanie, France
      Neurology department, Montpellier University Hospital
    Aug 19, 2022